1. Home /
  2. Drug Approvals

Drug Approvals

IPO Gives Chinese Couple a 'Hansoh' Sum

IPO Gives Chinese Couple a 'Hansoh' Sum

The initial public offering of Hansoh Pharmaceutical Group made the Chinese couple Zhong Huijuan and Sun Piaoyang the richest in the nation.

Jim Cramer: A Tale of Two Stocks

Jim Cramer: A Tale of Two Stocks

I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.

2 Small Biotechs With Sagging Shares but Promising Prospects

2 Small Biotechs With Sagging Shares but Promising Prospects

The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.

Buy Stocks at a Big Discount With These 7 Closed-End Funds

Buy Stocks at a Big Discount With These 7 Closed-End Funds

Closed-end funds provide several benefits to investors over mutual funds.

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly's plan to eliminate pain could have farther reaching positive effects than just migraines.

Watch These 9 Companies in a Botox Export Boom Out of South Korea

Watch These 9 Companies in a Botox Export Boom Out of South Korea

South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.

Amgen Shares Gain on Positive Lung-Cancer Trial Results

Amgen Shares Gain on Positive Lung-Cancer Trial Results

Shares of Amgen rise after the company announces positive initial trial results from its experimental drug used to treat non-small-cell lung cancer patients.

Ben & Jerry's Wants to Get in on CBD Craze

Ben & Jerry's Wants to Get in on CBD Craze

The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.

Merck to Acquire Peloton Therapeutics for About $1B in Cash

Merck to Acquire Peloton Therapeutics for About $1B in Cash

Merck agrees to buy privately held Peloton Therapeutics for $1 billion in cash, giving it access to Peloton's molecular therapy treatments for patients with cancer and other non-oncology diseases.

Pfizer Gains After Being Named 'Top Pick' by Credit Suisse

Pfizer Gains After Being Named 'Top Pick' by Credit Suisse

Shares of Pfizer rise Thursday after the drugmaker is named a 'top pick' at Credit Suisse following a meeting the analysts had with Pfizer's management team.